Delayed and denied: The challenges faced by Canadians with rare disorders
Fewer new drugs for rare disorders come to Canada relative to the US and Europe. Canada has set-up barriers that delay or deny access to new drugs for many patients with unmet or poorly met healthcare needs. This leaves vulnerable Canadians at a serious disadvantage. This webinar will highlight how these barriers impact Canadians […]